Dual biologic therapy may help patients with refractory Crohn’s disease avoid avoid disease progression and recurrent surgery, preliminary data suggest. A North American study examined outcomes of trials of simultaneous biologic therapy in 22 patients whose disease was refractory to an average of four individual biologics. The vast majority of patients (91%) had experienced prior ...
Dual biologic therapy may be an option for people with refractory Crohn’s disease
By Mardi Chapman
21 May 2020